Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,937 DKK | +0.31% | +0.55% | -10.12% |
May. 21 | Genmab A/S Reaffirms Financial Guidance for 2024 | CI |
May. 21 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GENMAB A/S | Bio Therapeutic Drugs | +0.31% | +0.55% | -10.12% | -28.92% | +68.80% | 18.16B |
Technical Rankings Surperformance
- Stock Market
- Equities
- GMAB Stock
- Charts Genmab A/S
- Comparison Chart